Title:
強化ワクチン
Document Type and Number:
Japanese Patent JP4205861
Kind Code:
B2
Abstract:
The invention relates to methods and materials involved in the treatment and prevention of various diseases such as infections and IgE-related diseases. Specifically, the invention relates to methods and materials that can be used to vaccinate a mammal against specific self or non-self antigens. For example, the methods and materials described herein can be used to reduce the effects of IgE antibodies within a mammal by reducing the amount of total and receptor bound IgE antibodies in the mammal. In addition, the invention provides vaccine conjugates, immunogenic polypeptides, nucleic acid molecules that encode immunogenic polypeptides, host cells containing the nucleic acid molecules that encode immunogenic polypeptides, and methods for making vaccine conjugates and immunogenic polypeptides as well as nucleic acid molecules that encode immunogenic polypeptides. Further, the invention provides an IgE vaccine that induces an anti-self IgE response in a mammal.
Inventors:
Hermann, Lars, Tea.
Application Number:
JP2000579167A
Publication Date:
January 07, 2009
Filing Date:
October 21, 1999
Export Citation:
Assignee:
Registencia Pharmaceuticals Arbe
International Classes:
C07K14/47; A61K39/395; C12N15/09; A61P11/06; A61P17/04; A61P31/04; A61P31/10; A61P31/12; A61P37/06; A61P43/00; C07K16/42; C12N1/15; C12N1/19; C12N5/10; C12P21/08
Domestic Patent References:
| JP6510768A | ||||
| JP2503056A |
Other References:
EMBO.J.10,p.101-107(1991)
Attorney, Agent or Firm:
Yusuke Hiraki
Ishii Teiji
Satoshi Fujita
Yuko Matsuniya
Ishii Teiji
Satoshi Fujita
Yuko Matsuniya